Socioeconomic position and inflammatory and immune biomarkers of cardiovascular disease: Applications to the panel study of income dynamics

Biodemography and Social Biology

Volumn 55, Issue 2, 2009, Pages 178-205

  Aiello, Allison E ^a   Kaplan, George A ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77958013158     PISSN: 19485565     EISSN: 19485573     Source Type: Journal    
DOI: 10.1080/19485560903382304     Document Type: Article

References (203)

1. Adam, E. K., L. C. Hawkley, et al. 2006. Day-to-day dynamics of experience-Cortisol associations in a population-based sample of older adults. Proc. Natl. Acad. Sci. U S A 103 (45):17058-17063.
2. Aiello, A. E., A. Diez-Roux, A. M. Noone, N. Ranjit, M. Cushman, M. Tsai, and M. Szklo. Under review. Socioeconomic and psychosocial gradients in cardiovascular pathogen burden and immune response: The multi-ethnic study of atherosclerosis. Brain. Behav. Immun.
3. Alley, D. E., T. E. Seeman, J. Ki Kim, A. Karlamangla, P. Hu, and E. M. Crimmins. 2005. Socioeconomic status and C-reactive protein levels in the US population: NHANES IV. Brain. Behav. Immun.
4. Anderson, R. N., and B. L. Smith. 2005. Deaths: Leading causes for 2002. Natl. Vital Stat. Rep. 53 (17):1-89.
5. Appels, A., F. W. Bar, et al. 2000. Inflammation, depressive symptomtology, and coronary artery disease. Psychosom. Med. 62 (5):601-605.
6. Arnetz, B. B., S. O. Brenner, et al. 1991. Neuroendocrine and immunologic effects of unemployment and job insecurity. Psychother. Psychosom. 55 (2-4): 76-80.
7. Ashavaid, T. F., A. A. Kondkar, et al. 2005. Lipid, lipoprotein, apolipoprotein and lipoprotein (a) levels: Reference intervals in a healthy Indian population. J. Atheroscler. Thromb. 12 (5):251-259.
8. Aziz, N., J. L. Fahey, et al. 2003. Analytical performance of a highly sensitive C-reactive proteinbased immunoassay and the effects of laboratory variables on levels of protein in blood. Clin. Diagn. Lab. Immunol. 10 (4):652-657.
9. Baltrus, P. T., J. W. Lynch, et al. 2005. Race/ethnicity, life-course socioeconomic position, and body weight trajectories over 34 years: The Alameda County Study. Am. J. Publ. Health 95 (9):1595-1601.
10. Barnes, P. J. 2006. Corticosteroids: The drugs to beat. Eur. J. Pharmacol. 533 (1-3): 2-14.
11. Bastard, J. P., C. Jardel, et al. 1999. Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects. Circulation 99 (16):2221-2222.
12. Basterzi, A. D., C. Aydemir, et al. 2005. IL-6 levels decrease with SSRI treatment in patients with major depression. Hum. Psychopharmacol. 20 (7):473-476.
13. Baum, A., J. P. Garofalo, et al. 1999. Socioeconomic status and chronic stress. Does stress account for SES effects on health? Ann. N Y Acad. Sci. 896:131-144.
14. Bazzano, L. A., M. K. Serdula, et al. 2003. Dietary intake of fruits and vegetables and risk of cardiovascular disease. Curr. Atheroscler. Rep. 5 (6):492-499.
15. Bernal-Mizrachi, L., W. Jy, et al. 2003. High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am. Heart J. 145 (6):962-970.
16. Blair, S. N., J. B. Kampert, et al. 1996. Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women. JAMA 276 (3):205-210.
17. Brandtstadter, J., B. Baltes-Gotz, et al. 1991. Developmental and personality correlates of adrenocortical activity as indexed by salivary cortisol: Observations in the age range of 35 to 65 years. J. Psychosom. Res. 35 (2-3): 173-185.
18. Breen, E. C., M. McDonald, et al. 2000. Cytokine gene expression occurs more rapidly in stimulated peripheral blood mononuclear cells from human immunodeficiency virus-infected persons. Clin. Diagn. Lab Immunol. 7 (5):769-773.
19. Busti, A. J., J. S. Hooper, et al. 2005. Effects of perioperative antiinflammatory and immunomodulating therapy on surgical wound healing. Pharmacotherapy 25 (11):1566-1591.
20. Cacciari, E. 1988. L'obesita come fattore di rischio nel bambino. Ann. Esp. Pediatr. 29 (Suppl 32):267-271.
21. Casas, J. P., T. Shah, et al. 2008. C-reactive protein and coronary heart disease: A critical review. J. Intern. Med. 264 (4):295-314.
22. Cermak, J., N. S. Key, et al. 1993. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 82 (2):513-520.
23. Cerne, D., G. Ledinski, et al. 2000. Comparison of laboratory parameters as risk factors for the presence and the extent of coronary or carotid atherosclerosis: The significance of apolipoprotein B to apolipoprotein all ratio. Clin. Chem. Lab. Med. 38 (6):529-538.
24. Cheng, M., S. Hashmi, et al. 2008. Relationships of adiponectin and matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio with coronary plaque morphology in patients with acute coronary syndrome. Can. J. Cardiol. 24 (5):385-390.
25. Chiesa, G., and C. R. Sirtori. 2003. Recombinant apolipoprotein A-I (Milano): A novel agent for the induction of regression of atherosclerotic plaques. Ann. Med. 35 (4):267-273.
26. Cohen, S. 2005. Keynote Presentation at the Eighth International Congress of Behavioral Medicine: The Pittsburgh common cold studies: Psychosocial predictors of susceptibility to respiratory infectious illness. Int. J. Behav. Med. 12 (3):123-131.
27. Cohen, S., E. Frank, et al. 1998. Types of stressors that increase susceptibility to the common cold in healthy adults. Health Psychol. 17 (3):214-223.
28. Cohen, S., R. C. Kessler, and L. Underwood Gordon. 1995. Strategies for measuring stress in studies of psychiatric and physical disorders. In Measuring stress: A guide for health and social scientists, 3-26.
29. Cook, D. G., P. H. Whincup, et al. 1999. Fibrinogen and factor VII levels are related to adiposity but not to fetal growth or social class in children aged 10-11 years. Am. J. Epidemiol. 150 (7):727-736.
30. Danesh, J., R. Collins, et al. 1998. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: Meta-analyses of prospective studies. JAMA 279 (18):1477-1482.
31. Danesh, J., P. Whincup, et al. 2000. Chlamydia pneumoniae IgG titres and coronary heart disease: Prospective study and meta-analysis. BMJ 321 (7255):208-213.
32. de Maat, M. P., A. C. de Bart, et al. 1996. Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris. Arterioscler. Thromb. Vasc. Biol. 16 (9):1156-1162.
33. de Nigris, F., A. Lerman, et al. 2003. Oxidation-sensitive mechanisms, vascular apoptosis and atherosclerosis. Trends Mol. Med. 9 (8):351-359.
34. Diez Roux, A. V., S. S. Merkin, et al. 2001. Neighborhood of residence and incidence of coronary heart disease. N. Engl. J. Med. 345 (2):99-106.
35. Di Napoli, M., M. Schwaninger, et al. 2005. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: A statement for health care professionals from the CRP Pooling Project members. Stroke 36 (6):1316-1329.
36. Dotsenko, O., J. Chackathayil, et al. 2008. Candidate circulating biomarkers for the cardiovascular disease continuum. Curr. Pharm. Des. 14 (24):2445-2461.
37. Dowd, J. B., A. E. Aiello, et al. 2009. Socioeconomic disparities in the seroprevalence of cytomegalovirus infection in the US population: NHANES III. Epidemiol. Infect. 137 (1):58-65.
38. Dowd, J. B., and N. Goldman. 2006. Do biomarkers of stress mediate the relation between socioeconomic status and health? J. Epidemiol. Community Health 60 (7):633-639.
39. Dowd, J. B., M. N. Haan, et al. 2008. Socioeconomic gradients in immune response to latent infection. Am. J. Epidemiol. 167 (1):112-120.
40. Doyle, W. J., D. A. Gentile, et al. 2006. Emotional style, nasal cytokines, and illness expression after experimental rhinovirus exposure. Brain Behav. Immun. 20 (2):175-181.
41. Dugue, B., and E. Leppanen. 1998. Short-term variability in the concentration of serum interleukin-6 and its soluble receptor in subjectively healthy persons. Clin. Chem. Lab. Med. 36 (5):323-325.
42. Eid, H. M., T. Lyberg, et al. 2002. Reactive oxygen species generation by leukocytes in populations at risk for atherosclerotic disease. Scand. J. Clin. Lab. Invest. 62 (6):431-439.
43. Epstein, S. E. 2002. The multiple mechanisms by which infection may contribute to atherosclerosis development and course. Circ. Res. 90 (1):2-4.
44. Ferguson, M. A., B. Gutin, S. Owens, M. Litaker, R. P. Tracy, and J. Allison. 1998. Fat distribution and hemostatic measures in obese children. Am. J. Clin. Nutr. 67 (6):1136-1140.
45. Fichorova, R. N., N. Richardson-Harman, et al. 2008. Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid: A multicenter study. Anal. Chem. 80 (12):4741-4751.
46. Fichtlscherer, S., G. Rosenberger, et al. 2000. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation 102 (9):1000-1006.
47. Finch, C. E., J. W. Vaupel, et al. 2001. Cells and surveys: Should biological measures be included in social science research? Washington, DC: National Academies Press.
48. Flower, L., R. H. Ahuja, et al. 2000. Effects of sample handling on the stability of interleukin 6, tumour necrosis factor-alpha and leptin. Cytokine 12 (11):1712-1716.
49. Folsom, A. R., K. K. Wu, et al. 1997. Prospective study of hemostatic factors and incidence of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 96 (4):1102-1108.
50. Folsom, A. R., K. K. Wu, et al. 2000. Determinants of population changes in fibrinogen and factor VII over 6 years: The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler. Thromb. Vasc. Biol. 20 (2):601-606.
51. Ford, E. S., and W. H. Giles. 2000. Serum C-reactive protein and fibrinogen concentrations and selfreported angina pectoris and myocardial infarction: Findings from National Health and Nutrition Examination Survey III. J. Clin. Epidemiol. 53 (1):95-102.
52. Gallo, W. T., H. M. Teng, et al. 2006. The impact of late career job loss on myocardial infarction and stroke: A 10 year follow up using the health and retirement survey. Occup. Environ. Med. 63 (10):683-687.
53. Galobardes, B., J. W. Lynch, et al. 2008. Is the association between childhood socioeconomic circumstances and cause-specific mortality established? Update of a systematic review. J Epidemiol. Community Health 62 (5):387-390.
54. Galobardes, B., G. D. Smith, et al. 2006. Systematic review of the influence of childhood socioeconomic circumstances on risk for cardiovascular disease in adulthood. Ann. Epidemiol. 16 (2):91-104.
55. Georges, J. L., H. J. Rupprecht, et al. 2003. Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines. Am. J. Cardiol. 92 (5):515-521.
56. Girod, J. P., and D. J. Brotman. 2004. Does altered glucocorticoid homeostasis increase cardiovascular risk? Cardiovasc. Res. 64 (2):217-226.
57. Glaser, R., and J. K. Kiecolt-Glaser. 2005. Stress-induced immune dysfunction: Implications for health. Nat. Rev. Immunol. 5 (3):243-251.
58. Glaser, R., J. K. Kiecolt-Glaser, et al. 1985. Stress, loneliness, and changes in herpesvirus latency. J. Behav. Med. 8 (3):249-260.
59. Glaser, R., T. F. Robles, et al. 2003. Mild depressive symptoms are associated with amplified and prolonged inflammatory responses after influenza virus vaccination in older adults. Arch. Gen. Psychiatr. 60 (10):1009-1014.
60. Glowinska, B., M. Urban, et al. 2005. Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes. Metabolism 54 (8):1020-1026.
61. Goodman, E., B. S. McEwen, et al. 2005. Social inequalities in biomarkers of cardiovascular risk in adolescence. Psychosom. Med. 67 (1):9-15.
62. Gori, A. M., F. Cesari, et al. 2008. The balance between pro-and anti-inflammatory cytokines is associated with platelet aggregability in acute coronary syndrome patients. Atherosclerosis 202 (1):255-262.
63. Graham, J. E., T. F. Robles, et al. 2005. Hostility and pain are related to inflammation in older adults. Brain Behav. Immun. 20 (4):389-400.
64. Green, D., N. Foiles, et al. 2008. Elevated fibrinogen levels and subsequent subclinical atherosclerosis: The CARDIA Study. Atherosclerosis 202 (2):623-631.
65. Greenwood, J., L. Steinman, et al. 2006. Statin therapy and autoimmune disease: From protein prenylation to immunomodulation. Nat. Rev. Immunol. 6 (5):358-370.
66. Grotto, I., M. Huerta, et al. 2008. Hypertension and socioeconomic status. Curr. Opin. Cardiol. 23 (4):335-339.
67. Hae Guen, S., K. Eung Ju, et al. 2008. Relative contributions of different cardiovascular risk factors to significant arterial stiffness. Int. J. Cardiol.
68. Hak, A. E., C. D. Stehouwer, et al. 1999. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler. Thromb. Vasc. Biol. 19 (8):1986-1991.
69. Hellhammer, J., E. Fries, et al. 2007. Several daily measurements are necessary to reliably assess the cortisol rise after awakening: State-and trait components. Psychoneuroendocrinology 32 (1):80-86.
70. Herbert, T. B., and S. Cohen. 1993a. Depression and immunity: A meta-analytic review. Psychol. Bull. 113 (3):472-486.
71. Herbert, T. B., and S. Cohen. 1993b. Stress and immunity in humans: A meta-analytic review. Psychosom. Med. 55 (4):364-379.
72. Holvoet, P., D. H. Lee, et al. 2008. Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. JAMA 299 (19):2287-2293.
73. Hong, S., R. A. Nelesen, et al. 2006. The association of social status and blood pressure with markers of vascular inflammation. Psychosom. Med. 68 (4):517-523.
74. Houston, M. C. 2005. Nutraceuticals, vitamins, antioxidants, and minerals in the prevention and treatment of hypertension. Prog. Cardiovasc. Dis. 47 (6):396-449.
75. Hruschka, D. J., B. A. Kohrt, et al. 2005. Estimating between-and within-individual variation in cortisol levels using multilevel models. Psychoneuroendocrinology 30 (7):698-714.
76. Huang, H., W. Mai, et al. 2008. The oxidation ratio of LDL: A predictor for coronary artery disease. Dis. Markers 24 (6):341-349.
77. Huang, J., M. Okuka, M. McLean, D. L. Keefe, and L. Liu. 2009. Effects of cigarette smoke on fertilization and embryo development in vivo. Fertil. Steril. 92 (4):1456-1465.
78. Ignarro, L. J., M. L. Balestrieri, et al. 2007. Nutrition, physical activity, and cardiovascular disease: An update. Cardiovasc. Res. 73 (2):326-340.
79. Itabe, H. 2003. Oxidized low-density lipoproteins: What is understood and what remains to be clarified. Biol. Pharm. Bull. 26 (1):1-9.
80. Itabe, H. 2008. Oxidative modification of LDL: Its pathological role in atherosclerosis. Clin. Rev. Allergy Immunol. 37 (1):4-11.
81. Janicki-Deverts, D., S. Cohen, et al. 2008. History of unemployment predicts future elevations in C-Reactive protein among male participants in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Ann. Behav. Med. 36 (2):176-185.
82. Jankowiak, R., D. Zamzow, et al. 1998. Spectral characterization of fluorescently labeled catechol estrogen 3, 4-quinone-derived N7 guanine adducts and their identification in rat mammary gland tissue. Chem. Res. Toxicol. 11 (11):1339-1345.
83. Johnson, B. D., K. E. Kip, et al. 2004. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: The National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 109 (6):726-732.
84. Kaplan, G. A., and J. E. Keil. 1993. Socioeconomic factors and cardiovascular disease: A review of the literature. Circulation 88 (4 Pt 1):1973-1998.
85. Kauhanen, L., H. M. Lakka, et al. 2006. Social disadvantages in childhood and risk of all-cause death and cardiovascular disease in later life: A comparison of historical and retrospective childhood information. Int. J. Epidemiol. 35 (4):962-968.
86. Kestila, L., S. Koskinen, et al. 2006. Influence of parental education, childhood adversities, and current living conditions on daily smoking in early adulthood. Eur. J. Publ. Health 16 (6):617-626.
87. Kestila, L., T. Martelin, et al. 2008. Childhood and current determinants of heavy drinking in early adulthood. Alcohol Alcohol. 43 (4):460-469.
88. Kiecolt-Glaser, J. K., T. J. Loving, et al. 2005. Hostile marital interactions, proinflammatory cytokine production, and wound healing. Arch. Gen. Psychiatr. 62 (12):1377-1384.
89. Kiecolt-Glaser, J. K., L. McGuire, et al. 2002. Emotions, morbidity, and mortality: New perspectives from psychoneuroimmunology. Annu. Rev. Psychol. 53:83-107.
90. Kiecolt-Glaser, J. K., K. J. Preacher, et al. 2003. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc. Natl. Acad. Sci. U S A 100 (15):9090-9095.
91. Kim, C. S., H. S. Park, et al. 2006. Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters. Int. J. Obes. 30 (9):1347-1355.
92. Kirschbaum, C., and D. H. Hellhammer 1994. Salivary cortisol in psychoneuroendocrine research: Recent developments and applications. Psychoneuroendocrinology 19 (4):313-333.
93. Koba, S., T. Hirano, et al. 2006. Significance of small dense low-density lipoprotein-cholesterol concentrations in relation to the severity of coronary heart diseases. Atherosclerosis 189 (1):206-214.
94. Koenig, W., M. Sund, et al. 1999. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99 (2):237-242.
95. Kokkinos, P. 2008. Physical activity and cardiovascular disease prevention: Current recommendations. Angiology 59 (2 Suppl): 26S-29S.
96. Kokkinos, P., J. Myers, et al. 2008. Exercise capacity and mortality in black and white men. Circulation 117 (5):614-622.
97. Kristenson, M., H. R. Eriksen, J. K. Sluiter, D. Starke, and H. Ursin. 2004. Psychobiological mechanisms of socioeconomic differences in health. Soc. Sci. Med. 58 (8):1511-1522.
98. Kropf, J., J. O. Schurek, et al. 1997. Immunological measurement of transforming growth factor-beta 1 (TGF-beta1) in blood; assay development and comparison. Clin. Chem. 43 (10):1965-1974.
99. Kuby, J. 1997. Immunology. New York: Freeman and Company.
100. Kuller, L. H., R. P. Tracy, et al. 1996. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. Am. J. Epidemiol. 144 (6):537-547.
101. Kvarnstrom, A., R. Karlsten, et al. 2004. The analgesic effect of intravenous ketamine and lidocaine on pain after spinal cord injury. Acta Anaesthesiol. Scand. 48 (4):498-506.
102. Leaf, D. A., M. T. Kleinman, et al. 1999. The exercise-induced oxidative stress paradox: The effects of physical exercise training. Am. J. Med. Sci. 317 (5):295-300.
103. Leeuwenburgh, C., and J. W. Heinecke 2001. Oxidative stress and antioxidants in exercise. Curr. Med. Chem. 8 (7):829-838.
104. Leppanen, E., and B. Dugue 1998. When to collect blood specimens: Midmorning vs fasting samples. Clin. Chem. 44 (12):2537-2542.
105. Levine, A., O. Zagoory-Sharon, et al. 2007. Measuring cortisol in human psychobiological studies. Physiol. Behav. 90 (1):43-53.
106. Libby, P. 2001. What have we learned about the biology of atherosclerosis? The role of inflammation. Am. J. Cardiol. 88 (7 B): 3J-6J.
107. Lopez, A. D., and C. C. Murray 1998. The global burden of disease, 1990-2020. Nat. Med. 4 (11):1241-1243.
108. Loucks, E. B., L. M. Sullivan, et al. 2006. Association of educational level with inflammatory markers in the Framingham Offspring Study. Am. J. Epidemiol. 163 (7):622-628.
109. Macy, E. M., T. E. Hayes, et al. 1997. Variability in the measurement of C-reactive protein in healthy subjects: Implications for reference intervals and epidemiological applications. Clin. Chem. 43 (1):52-58.
110. Manson, J. E., F. B. Hu, et al. 1999. A prospective study of walking as compared with vigorous exercise in the prevention of coronary heart disease in women. N. Engl. J. Med. 341 (9):650-658.
111. Markowe, H. L., M. G. Marmot, et al. 1985. Fibrinogen: A possible link between social class and coronary heart disease. Br. Med. J. 291 (6505):1312-1314.
112. McDade, T. W., J. Burhop, et al. 2004. High-sensitivity enzyme immunoassay for C-reactive protein in dried blood spots. Clin. Chem. 50 (3):652-654.
113. McDade, T. W., J. F. Stallings, et al. 2000. Epstein-Barr virus antibodies in whole blood spots: A minimally invasive method for assessing an aspect of cell-mediated immunity. Psychosom. Med. 62 (4):560-567.
114. McDade, T. W., S. Williams, et al. 2007. What a drop can do: Dried blood spots as a minimally invasive method for integrating biomarkers into population-based research. Demography 44 (4):899-925.
115. McEwen, B. S. 2000. Effects of adverse experiences for brain structure and function. Biol. Psychiatr. 48 (8):721-731.
116. Mendall, M. A., P. Patel, et al. 1996. C reactive protein and its relation to cardiovascular risk factors: A population based cross sectional study. BMJ 312 (7038):1061-1065.
117. Miller, G. E., K. E. Freedland, et al. 2005a. Depressive symptoms and the regulation of proinflammatory cytokine expression in patients with coronary heart disease. J. Psychosom. Res. 59 (4):231-236.
118. Miller, G. E., K. E. Freedland, et al. 2005b. Relation of depressive symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes simplex virus, Epstein-Barr virus) in patients with earlier acute coronary syndromes. Am. J. Cardiol. 95 (3):317-321.
119. Mohamed-Ali, V., S. Goodrick, et al. 1997. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J. Clin. Endocrinol. Metab. 82 (12):4196-4200.
120. Muennig, P., N. Sohler, et al. 2007. Socioeconomic status as an independent predictor of physiological biomarkers of cardiovascular disease: Evidence from NHANES. Prev. Med. 45 (1):35-40.
121. Muhlestein, J. B., J. L. Anderson, et al. 1998. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation 97 (7):633-636.
122. Myers, J., M. Prakash, et al. 2002. Exercise capacity and mortality among men referred for exercise testing. N. Engl. J. Med. 346 (11):793-801. (Pubitemid 34987553)
123. Napoleao, P., M. C. Santos, et al. 2007. Variations in inflammatory markers in acute myocardial infarction: A longitudinal study. Rev. Port. Cardiol. 26 (12):1357-1363.
124. Napoli, C., S. Williams-Ignarro, et al. 2004. Long-term combined beneficial effects of physical training and metabolic treatment on atherosclerosis in hypercholesterolemic mice. Proc. Natl. Acad. Sci. U S A 101 (23):8797-8802.
125. Nauck, M., M. S. Graziani, et al. 2000. Analytical and clinical performance of a detergent-based homogeneous LDL-cholesterol assay: A multicenter evaluation. Clin. Chem. 46 (4):506-514.
126. Nazmi, A., and C. G. Victora. 2007. Socioeconomic and racial/ethnic differentials of C-reactive protein levels: A systematic review of population-based studies. BMC Publ. Health 7:212.
127. O'Brien, K. A., S. Ling, et al. 2008. A Chinese herbal preparation containing Radix Salviae miltiorrhizae, Radix notoginseng and Borneolum syntheticum reduces circulating adhesion molecules. Evid. Base. Compl. Alternative Med.
128. Ockene, I. S., C. E. Matthews, et al. 2001. Variability and classification accuracy of serial highsensitivity C-reactive protein measurements in healthy adults. Clin. Chem. 47 (3):444-450.
129. Owen, N., T. Poulton, et al. 2003. Socioeconomic status, C-reactive protein, immune factors, and responses to acute mental stress. Brain Behav. Immun. 17 (4):286-295. (Pubitemid 36794149)
130. Pariante, C. M., B. Carpiniello, et al. 1997. Chronic caregiving stress alters peripheral blood immune parameters: The role of age and severity of stress. Psychother. Psychosom. 66 (4):199-207.
131. Park, H. J., P. H. Lee, et al. 2007. Neuroprotective effect of nicotine on dopaminergic neurons by anti-inflammatory action. Eur. J. Neurosci. 26 (1):79-89.
132. Pasceri, V., J. T. Willerson, et al. 2000. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102 (18):2165-2168.
133. Pickering, T. 1999. Cardiovascular pathways: Socioeconomic status and stress effects on hypertension and cardiovascular function. Ann. N Y Acad. Sci. 896:262-277.
134. Pirro, M., G. Schillaci, et al. 2006. Increased ratio of CD31+/CD42-microparticles to endothelial progenitors as a novel marker of atherosclerosis in hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 26 (11):2530-2535.
135. Pollitt, R. A., J. S. Kaufman, et al. 2007. Early-life and adult socioeconomic status and inflammatory risk markers in adulthood. Eur. J. Epidemiol. 22 (1):55-66.
136. Pollitt, R. A., J. S. Kaufman, et al. 2008. Cumulative life course and adult socioeconomic status and markers of inflammation in adulthood. J. Epidemiol. Community Health 62 (6):484-491.
137. Power, C., K. Atherton, et al. 2007. Life-course influences on health in British adults: Effects of socio-economic position in childhood and adulthood. Int. J. Epidemiol. 36 (3):532-539. (Pubitemid 47244550)
138. Pradhan, A. D., J. E. Manson, et al. 2001. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286 (3):327-334.
139. Profumo, E., B. Buttari, et al. 2008. Association of intracellular pro-and anti-inflammatory cytokines in peripheral blood with the clinical or ultrasound indications for carotid endarterectomy in patients with carotid atherosclerosis. Clin. Exp. Immunol. 152 (1):120-126.
140. Rader, D. J. 2000. Inflammatory markers of coronary risk. N. Engl. J. Med. 343 (16):1179-1182.
141. Ramsay, S., G. D. Lowe, et al. 2008. Relationships of inflammatory and haemostatic markers with social class: Results from a population-based study of older men. Atherosclerosis 197 (2):654-661. (Pubitemid 351417862)
142. Ranga, G. S., O. P. Kalra, et al. 2007. Effect of aspirin on lipoprotein (a) in patients with ischemic stroke. J. Stroke Cerebrovasc. Dis. 16 (5):220-224.
143. Ranjit, N., A. V. Diez-Roux, et al. 2007. Socioeconomic position, race/ethnicity, and inflammation in the multi-ethnic study of atherosclerosis. Circulation 116 (21):2383-2390. (Pubitemid 350145073)
144. Ranjit, N., E. A. Young, et al. 2005. Material hardship alters the diurnal rhythm of salivary cortisol. Int. J. Epidemiol. 34 (5):1138-1143.
145. Rao, K. M., C. S. Pieper, et al. 1994. Variability of plasma IL-6 and crosslinked fibrin dimers over time in community dwelling elderly subjects. Am. J. Clin. Pathol. 102 (6):802-805.
146. Ridker, P. M., M. Cushman, et al. 1997. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 336 (14):973-979.
147. Ridker, P. M., C. H. Hennekens, et al. 2000. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342 (12):836-843.
148. Ridker, P. M., N. Rifai, et al. 2000. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101 (15):1767-1772.
149. Rifai, N., R. Joubran, et al. 1999. Inflammatory markers in men with angiographically documented coronary heart disease. Clin. Chem. 45 (11):1967-1973.
150. Rogatsky, I., and L. B. Ivashkiv 2006. Glucocorticoid modulation of cytokine signaling. Tissue Antigens 68 (1):1-12.
151. Rosa-Fraile, M., A. Sampedro, et al. 2004. Suitability of frozen serum stored in gel separator primary sampling tubes for serological testing. Clin. Diagn. Lab. Immunol. 11 (1):219-221.
152. Rosengren, A., L. Wilhelmsen, et al. 1990. Social influences and cardiovascular risk factors as determinants of plasma fibrinogen concentration in a general population sample of middle aged men. BMJ 300 (6725):634-638.
153. Ross, R. 1999. Atherosclerosis - An inflammatory disease. N. Engl. J. Med. 340 (2):115-126.
154. Rosvall, M., G. Engstrom, et al. 2007. The role of low grade inflammation as measured by C-reactive protein levels in the explanation of socioeconomic differences in carotid atherosclerosis. Eur. J. Publ. Health 17 (4):340-347.
155. Rudolph, T. K., V. Rudolph, et al. 2008. Contribution of myeloperoxidase to smoking-dependent vascular inflammation. Proc. Am. Thorac. Soc. 5 (8):820-823.
156. Schillinger, J. A., F. Xu, et al. 2004. National seroprevalence and trends in herpes simplex virus type 1 in the United States, 1976-1994. Sex. Transm. Dis. 31 (12):753-760.
157. Schumacher, A., I. Seljeflot, et al. 2005. Chlamydia LPS and MOMP seropositivity are associated with different cytokine profiles in patients with coronary heart disease. Eur. J. Clin. Invest. 35 (7):431-437.
158. Seeman, T. E., and E. Crimmins. 2001. Social environment effects on health and aging: Integrating epidemiologic and demographic approaches and perspectives. Ann. N Y Acad. Sci. 954:88-117.
159. Shea, S., C. R. Isasi, S. Couch, T. J. Starc, R. P. Tracy, R. Deckelbaum, P. Talmud, L. Berglund, and S. E. Humphries. 1999. Relations of plasma fibrinogen level in children to measures of obesity, the (G-455->A) mutation in the beta-fibrinogen promoter gene, and family history of ischemic heart disease: The Columbia University BioMarkers Study. Am. J. Epidemiol. 150 (7):737-746.
160. Simanek, A. M., J. B. Dowd, A. E. Aiello. 2009. Persistent pathogens linking socioeconomic position and cardiovascular disease in the US. Int. J. Epidemiol. 38 (3):775-787.
161. Sisman, A. R., T. Kume, et al. 2007. Comparison and evaluation of two C-reactive protein assays based on particle-enhanced immunoturbidimetry. J. Clin. Lab. Anal. 21 (2):71-76.
162. Soderberg-Naucler, C. 2006. Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer? J. Intern. Med. 259 (3):219-246.
163. Souza, J. R., R. T. Oliveira, et al. 2008. Serum levels of interleukin-6 (Il-6), interleukin-18 (Il-18) and C-reactive protein (CRP) in patients with type-2 diabetes and acute coronary syndrome without ST-segment elevation. Arq. Bras. Cardiol. 90 (2):86-90.
164. Staras, S. A., S. C. Dollard, et al. 2006. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin. Infect. Dis. 43 (9):1143-1151.
165. Steffens, S., and F. Mach. 2006. Drug insight: Immunomodulatory effects of statins-Potential benefits for renal patients? Nat. Clin. Pract. Nephrol. 2 (7):378-387.
166. Steinberg, D., and J. L. Witztum. 2002. Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis? Circulation 105 (17):2107-2111.
167. Steptoe, A., S. Kunz-Ebrecht, et al. 2003a. Influence of socioeconomic status and job control on plasma fibrinogen responses to acute mental stress. Psychosom. Med. 65 (1):137-144.
168. Steptoe, A., S. Kunz-Ebrecht, et al. 2003b. Prolonged elevations in haemostatic and rheological responses following psychological stress in low socioeconomic status men and women. Thromb. Haemost. 89 (1):83-90.
169. Steptoe, A., and M. Marmot 2002. The role of psychobiological pathways in socio-economic inequalities in cardiovascular disease risk. Eur. Heart J. 23 (1):13-25.
170. Steptoe, A., N. Owen, et al. 2002. Inflammatory cytokines, socioeconomic status, and acute stress responsivity. Brain Behav. Immun. 16 (6):774-784.
171. Steptoe, A., A. Shamaei-Tousi, et al. 2007. Socioeconomic status, pathogen burden and cardiovascular disease risk. Heart 93 (12):1567-1570.
172. Sternberg, E. M. 1997. Emotions and disease: From balance of humors to balance of molecules. Nat. Med. 3 (3):264-267.
173. Stowe, R. P., S. K. Mehta, et al. 2001. Immune responses and latent herpesvirus reactivation in spaceflight. Aviat. Space Environ. Med. 72 (10):884-891.
174. Strike, P. C., and A. Steptoe. 2004. Psychosocial factors in the development of coronary artery disease. Prog. Cardiovasc. Dis. 46 (4):337-347.
175. Tabassum, F., M. Kumari, et al. 2008. Effects of socioeconomic position on inflammatory and hemostatic markers: A life-course analysis in the 1958 British birth cohort. Am. J. Epidemiol. 167 (11):1332-1341.
176. Takaoka, N., L. A. Campbell, et al. 2008. Chlamydia pneumoniae infection increases adherence of mouse macrophages to mouse endothelial cells in vitro and to aortas ex vivo. Infect. Immun. 76 (2):510-514.
177. Tesfamariam, B., and A. F. DeFelice. 2007. Endothelial injury in the initiation and progression of vascular disorders. Vasc. Pharmacol. 46 (4):229-237.
178. Tolando, R., A. Jovanovic, et al. 2000. Reactive oxygen species and proinflammatory cytokine signaling in endothelial cells: Effect of selenium supplementation. Free Radic. Biol. Med. 28 (6):979-986.
179. Torzewski, M., C. Rist, et al. 2000. C-reactive protein in the arterial intima: Role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler. Thromb. Vasc. Biol. 20 (9):2094-2099.
180. Tracy, R. P. 2001. Is visceral adiposity the enemy within? Arterioscler. Thromb. Vasc. Biol. 21 (6):881-883.
181. Tworoger, S. S. and S. E. Hankinson. 2006. Use of biomarkers in epidemiologic studies: Minimizing the influence of measurement error in the study design and analysis. Canc. Causes Contr. 17 (7):889-899.
182. Vallance, P., J. Collier, et al. 1997. Infection, inflammation, and infarction: Does acute endothelial dysfunction provide a link? Lancet 349 (9062):1391-1392.
183. Vedhara, K., N. K. Cox, et al. 1999. Chronic stress in elderly carers of dementia patients and antibody response to influenza vaccination. Lancet 353 (9153):627-631. (Pubitemid 29087983)
184. Vedhara, K., J. D. Fox, et al. 1999. The measurement of stress-related immune dysfunction in psychoneuroimmunology. Neurosci. Biobehav. Rev. 23 (5):699-715.
185. Vineis, P. 1997. Sources of variation in biomarkers. IARC Sci. Publ. (142):59-71.
186. Visser, M., L. M. Bouter, G. M. McQuillan, M. H. Wener, and T. B. Harris. 1999. Elevated C-reactive protein levels in overweight and obese adults. JAMA 282 (22):2131-2135.
187. Wamala, S. P., J. Lynch, et al. 2001. Women's exposure to early and later life socioeconomic disadvantage and coronary heart disease risk: The Stockholm Female Coronary Risk Study. Int. J. Epidemiol. 30 (2):275-284.
188. Wettero, J., L. Nilsson, et al. 2008. Reduced serum levels of autoantibodies against monomeric C-reactive protein (CRP) in patients with acute coronary syndrome. Clin. Chim. Acta. 400 (1-2): 128-131.
189. Wilhelmsen, L., K. Svardsudd, et al. 1984. Fibrinogen as a risk factor for stroke and myocardial infarction. N. Engl. J. Med. 311 (8):501-505.
190. Wilson, P. W. 2004. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: Ability of inflammatory markers to predict disease in asymptomatic patients: A background paper. Circulation 110(25):e568-e571.
191. Wilson, T. W., G. A. Kaplan, et al. 1993. Association between plasma fibrinogen concentration and five socioeconomic indices in the Kuopio Ischemic Heart Disease Risk Factor Study. Am. J. Epidemiol. 137 (3):292-300.
192. Wong, E., M. Freiberg, et al. 2008. Epidemiology of cytokines: The Women On the Move through Activity and Nutrition (WOMAN) Study. Am. J. Epidemiol. 168 (4):443-453.
193. Xu, F., J. A. Schillinger, et al. 2002. Seroprevalence and coinfection with herpes simplex virus type 1 and type 2 in the United States, 1988-1994. J. Infect. Dis. 185 (8):1019-1024.
194. Yarnell, J., S. Yu, et al. 2005. Education, socioeconomic and lifestyle factors, and risk of coronary heart disease: The PRIME Study. Int. J. Epidemiol. 34 (2):268-275.
195. Yehuda, R., S. L. Halligan, et al. 2003. Relationship between 24-hour urinary-free cortisol excretion and salivary cortisol levels sampled from awakening to bedtime in healthy subjects. Life Sci. 73 (3):349-358.
196. Young, E. A., J. Abelson, et al. 2004. Cortisol pulsatility and its role in stress regulation and health. Front. Neuroendocrinol. 25 (2):69-76.
197. Yudkin, J. S., C. D. Stehouwer, J. J. Emeis, and S. W. Coppack. 1999. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue? Arterioscler. Thromb. Vasc. Biol. 19 (4):972-978.
198. Yu-Poth, S., G. Zhao, et al. 1999. Effects of the National Cholesterol Education Program's Step I and Step II dietary intervention programs on cardiovascular disease risk factors: A meta-analysis. Am. J. Clin. Nutr. 69 (4):632-646.
199. Zajacova, A., J. B. Dowd, et al. In press. Socioeconomic and race/ethnic patterns in persistent infection burden among U. S. adults. J. Gerontol. Biol. Med. Sci. 64 (2):272-279.
200. Zhang, Y. X., W. J. Cliff, et al. 1999. Coronary C-reactive protein distribution: Its relation to development of atherosclerosis. Atherosclerosis 145 (2):375-379.
201. Zhu, J., F. J. Nieto, et al. 2001. Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation 103 (1):45-51.
202. Zhu, J., A. A. Quyyumi, et al. 2000. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am. J. Cardiol. 85 (2):140-106.
203. Zweerink, H. J., and L. W. Stanton. 1981. Immune response to herpes simplex virus infections: Virus-specific antibodies in sera from patients with recurrent facial infections. Infect. Immun. 31 (2):624-630.